A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

NCT03329092 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-abdominal Infection
Hosptial Acquired Pneumonia
Ventilator Associated Pneumonia

Interventions

DRUG: ATM-AVI
DRUG: MTZ
DRUG: MER
DRUG: COL

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]